Financing
Stock Issuance Proceeds
Roivant Sciences Stock Issuance Proceeds decreased by 282.8% to -$217.17M in Q1 2026 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher proceeds often correlate with employee participation in stock-based compensation programs rather than external capital raising.
Detailed definition
Cash inflows resulting from the issuance of common stock, typically through employee stock option exercises or equity co...
Peer comparison
Standard for large-cap companies with significant equity-based compensation programs.
Metric ID:
proceeds_from_stock_issuanceHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $94.74M | $217.25M | $21.03M | $178.79M | $2.27M | -$2.27M | $0.00 | $0.00 | $30.06M | $68.29M | $118.81M | -$217.17M |
| QoQ Change | — | — | — | — | — | — | — | +129.3% | -90.3% | +750.3% | -98.7% | -200.0% | +100.0% | — | — | +127.2% | +74.0% | -282.8% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | -89.2% | -101.3% | — | — | >999% | >999% | — | — |
Range-$217.17M – $217.25M
Avg YoY Growth>999%
Median YoY Growth+567.2%
Stock Issuance Proceeds at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's stock issuance proceeds?
- Roivant Sciences (ROIV) reported stock issuance proceeds of -$217.17M in Q1 2026.
- What does stock issuance proceeds mean?
- Cash received from the sale or issuance of company stock.